Stonepine Capital Management »

Codexis shares owned by Stonepine Capital Management

Quarter-by-quarter ownership of Codexis (CDXS) shares owned by Stonepine Capital Management from 13F filings

Historical chart of Stonepine Capital Management investment in Codexis

Tip: Access up to 7 years of quarterly data

All positions including Codexis held by Stonepine Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Codexis by Stonepine Capital Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $215k 88k 2.44

More positions owned by Stonepine Capital Management

Verastem Com New (VSTM)
Adma Biologics (ADMA)
Evolus (EOLS)
Zevra Therapeutics Com New (ZVRA)
Nektar Therapeutics Com New (NKTR)
Day One Biopharmaceuticals I (DAWN)
Xoma Royalty Corporation Com New (XOMA)
ACADIA Pharmaceuticals (ACAD)
Enanta Pharmaceuticals (ENTA)
X4 Pharmaceuticals Com New (XFOR)
Omniab (OABI)
Surrozen Com New (SRZN)
Tela Bio (TELA)
Indivior Ord (INDV)
Abeona Therapeutics Com New (ABEO)

View all positions for Stonepine Capital Management

Top funds holding Codexis

Opaleye Management
BlackRock
Vanguard Group
Standard Life Aberdeen
Millennium Management
Nantahala Capital Management
Telemark Asset Management
Ameriprise Financial
Geode Capital Management
Pier Capital
State Street Corporation
Empire Financial Management Company
Jacobs Levy Equity Management
Nuveen
Franklin Resources

View all funds holding Codexis